Reaching development, regulatory and commercial milestones could see value of deal hit around US$2.75 billion Insilico Medicine has signed a potential multibillion-dollar deal with Eli Lilly to ...
Yuanjie's rise underscores how China's optical chip firms are riding the AI infrastructure boom, with data centre demand driving growth Yuanjie Semiconductor Technology, a Chinese maker of laser chips ...
March 29 () - Eli Lilly will sign a $2 billion deal with Hong Kong-listed biotech Insilico Medicine, which uses artificial ...
Given Hong Kong’s proximity to Shenzhen, an innovation hub for hardware and industrial AI, as well as the Guangdong-Hong Kong-Macau Greater Bay Area, the city is primed to grow into a regional high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results